{"id":71421,"date":"2026-05-20T10:30:00","date_gmt":"2026-05-20T10:30:00","guid":{"rendered":"https:\/\/medsbase.com\/5-amino-1mq\/"},"modified":"2026-10-15T10:33:57","modified_gmt":"2026-10-15T10:33:57","slug":"5-amino-1mq","status":"publish","type":"product","link":"https:\/\/medsbase.com\/ja\/product\/5-amino-1mq\/","title":{"rendered":"5-Amino-1MQ\uff085-\u30a2\u30df\u30ce-1-\u30e1\u30c1\u30eb\u30ad\u30ce\u30ea\u30cb\u30a6\u30e0 \u30e8\u30fc\u30b8\u30c9\uff09"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">\u30af\u30a4\u30c3\u30af\u30a2\u30f3\u30b5\u30fc \u2014 5-Amino-1MQ\u3068\u306f\uff1f<\/h3>\n<p style=\"margin: 0;\"><strong>5-Amino-1MQ<\/strong> \uff085-amino-1-methylquinolinium iodide, CAS 42464-96-0\uff09\u306f\u4f4e\u5206\u5b50\u3067\u3001\u57fa\u8cea\u90e8\u4f4d\u9078\u629e\u7684\u306a <strong>NNMT\uff08\u30cb\u30b3\u30c1\u30f3\u30a2\u30df\u30c9-N-\u30e1\u30c1\u30eb\u30c8\u30e9\u30f3\u30b9\u30d5\u30a7\u30e9\u30fc\u30bc\uff09\u963b\u5bb3\u5264<\/strong> \u516c\u8868\u3055\u308c\u3066\u3044\u308bIC<sub>50<\/sub> \u304c1.2 \u00b5M\u3067\u3042\u308b\u3053\u3068\u3002NNMT \u2014 \u30b5\u30a4\u30c8\u30be\u30eb\u9175\u7d20\u3067\u3001\u30cb\u30b3\u30c1\u30f3\u30a2\u30df\u30c9\uff08NAD\u306e\u524d\u99c6\u4f53<sup>+<\/sup>\uff09\u304a\u3088\u3073S-\u30a2\u30c7\u30ce\u30b7\u30eb-L-\u30e1\u30c1\u30aa\u30cb\u30f3\uff08SAM\u3001\u30e6\u30cb\u30d0\u30fc\u30b5\u30eb\u30e1\u30c1\u30eb\u30c9\u30ca\u30fc\uff09 \u2014 5-Amino-1MQ\u306f\u3001\u67fb\u8aad\u4ed8\u304d\u7814\u7a76\u3067\u7d30\u80de\u5185NAD<sup>+<\/sup> \u304a\u3088\u3073SAM\u30d7\u30fc\u30eb\u3092\u5897\u52a0\u3055\u305b\u30013T3-L1\u8102\u80aa\u7d30\u80de\u306e\u8102\u80aa\u751f\u6210\u3092\u6e1b\u5c11\u3055\u305b\u3001\u98df\u4e8b\u8a98\u5c0e\u6027\u80a5\u6e80\u30de\u30a6\u30b9\u30e2\u30c7\u30eb\uff0820 mg\/kg\/d\uff09\u3001\u7b4b\u5e79\u7d30\u80de\u4ecb\u5728\u4fee\u5fa9\u3001\u304a\u3088\u3073\u5375\u5de3\u764c\u8ee2\u79fb\u306b\u304a\u3044\u3066\u300160 mg\/kg\/d\u307e\u3067\u6709\u5bb3\u4f5c\u7528\u306a\u3057\u306b in vivo \u3067\u6709\u52b9\u6027\u3092\u793a\u3059\u3053\u3068\u304c\u5831\u544a\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u3053\u308c\u306f\u4f4e\u5206\u5b50\uff08<em>\u30da\u30d7\u30c1\u30c9\u3067\u306f\u3042\u308a\u307e\u305b\u3093<\/em>) supplied as a lyophilized powder.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>MedsBase\u3067\u5f97\u3089\u308c\u308b\u3082\u306e\uff1a<\/strong> Pharmaceutical-grade lyophilized peptides &middot; HPLC &ge;99% purity (COA on request) &middot; Discreet protective packaging &middot; Worldwide peptide courier &middot; 1,400+ verified <a href=\"https:\/\/medsbase.com\/ja\/reviews\/\">\u30ab\u30b9\u30bf\u30de\u30fc\u30ec\u30d3\u30e5\u30fc<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 \u3059\u3079\u3066\u306e\u3054\u6ce8\u6587\u306f\u3001\u5f53\u5e97\u306e <a href=\"https:\/\/medsbase.com\/ja\/medsbase-re-shipment-assurance-policy\/\"><strong>\u518d\u767a\u9001\u4fdd\u8a3c\u30dd\u30ea\u30b7\u30fc<\/strong><\/a> \u2014 \u4e07\u304c\u4e00\u300120\u55b6\u696d\u65e5\u4ee5\u5185\u306b\u5546\u54c1\u304c\u5c4a\u304b\u306a\u3044\u5834\u5408\u306f\u3001\u518d\u767a\u9001\u3044\u305f\u3057\u307e\u3059\u3002<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">\u4ed5\u69d8<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">\u8a73\u7d30<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u5316\u5408\u7269\u30af\u30e9\u30b9<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u4f4e\u5206\u5b50\u7b2c\u56db\u7d1a\u30a2\u30f3\u30e2\u30cb\u30a6\u30e0\u30ad\u30ce\u30ea\u30cb\u30a6\u30e0\u5869\uff1b\u9078\u629e\u7684NNMT\u963b\u5bb3\u5264\uff1b; <em>\u30da\u30d7\u30c1\u30c9\u3067\u306f\u3042\u308a\u307e\u305b\u3093<\/em><\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u5316\u5b66\u540d<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">5-\u30a2\u30df\u30ce-1-\u30e1\u30c1\u30eb\u30ad\u30ce\u30ea\u30cb\u30a6\u30e0 \u30e8\u30a6\u5316\u7269<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>CAS\u756a\u53f7<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">42464-96-0<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u5206\u5b50\u5f0f<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>10<\/sub>H<sub>11<\/sub>IN<sub>2<\/sub> \uff08\u30e8\u30a6\u5316\u7269\u5869\uff09<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u5206\u5b50\u91cf<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">286.11 g\/mol<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u4f5c\u7528\u6a5f\u5e8f<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u57fa\u8cea\u90e8\u4f4d\u9078\u629e\u7684\u30cb\u30b3\u30c1\u30f3\u30a2\u30df\u30c9N-\u30e1\u30c1\u30eb\u30c8\u30e9\u30f3\u30b9\u30d5\u30a7\u30e9\u30fc\u30bc\uff08NNMT\uff09\u963b\u5bb3\u5264\uff1bIC<sub>50<\/sub> = 1.2 \u00b5M\uff08\u30a2\u30c3\u30bb\u30a4\uff1a50 \u00b5M SAM\u3001100 \u00b5M \u30cb\u30b3\u30c1\u30f3\u30a2\u30df\u30c9\uff09\u3002\u95a2\u9023\u30e1\u30c1\u30eb\u30c8\u30e9\u30f3\u30b9\u30d5\u30a7\u30e9\u30fc\u30bc\uff08GNMT\u3001PNMT\u3001COMT\uff09\u307e\u305f\u306fNAD\u3092\u963b\u5bb3\u3057\u306a\u3044\u3002<sup>+<\/sup>-\u30b5\u30eb\u30d9\u30fc\u30b8\u9175\u7d20\uff08NAMPT\u3001NMNAT\uff09\u3002<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u914d\u5217<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u8a72\u5f53\u306a\u3057\uff08\u4f4e\u5206\u5b50\u30ad\u30ce\u30ea\u30cb\u30a6\u30e0\u5869 \u2014 \u30da\u30d7\u30c1\u30c9\u3067\u306f\u3042\u308a\u307e\u305b\u3093\uff09<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u5f62\u614b<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Lyophilized crystalline \/ powder (off-white to pale yellow); supplied in single-use vials<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u7d14\u5ea6<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599%\uff08HPLC\u691c\u8a3c\u6e08\u307f\u3001COA\u306f\u30ea\u30af\u30a8\u30b9\u30c8\u306b\u5fdc\u3058\u3066\u63d0\u4f9b\uff09\u2014 Sigma-Aldrich SML2832\u53c2\u7167\u30b0\u30ec\u30fc\u30c9\u306b\u4e00\u81f4<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u6eb6\u89e3\u6027<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u9ad8\u3044\u6c34\u6eb6\u6027\uff08\u7b2c\u56db\u7d1a\u30a2\u30f3\u30e2\u30cb\u30a6\u30e0\u5869\u306f\u89aa\u6c34\u6027\uff09\u3002\u9759\u83cc\u6c34\u3001\u6ec5\u83cc\u6c34\u3001\u307e\u305f\u306fPBS\u306b\u5bb9\u6613\u306b\u518d\u6eb6\u89e3\u3057\u3001\u6700\u5927\u7d0450 mg\/mL\u306e\u6fc3\u5ea6\u3067\u6c88\u6bbf\u3092\u751f\u3058\u307e\u305b\u3093\u3002\u307e\u305f\u3001DMSO\u306b\u53ef\u6eb6\u3067\u3001in vitro\u7d30\u80de\u57f9\u990a\u306e\u30b9\u30c8\u30c3\u30af\u8abf\u88fd\u306b\u4f7f\u7528\u3067\u304d\u307e\u3059\u3002<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u4fdd\u7ba1\u65b9\u6cd5<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u51cd\u7d50\u4e7e\u71e5\u54c1\uff1a2\uff5e8 \u00b0C\u3067\u77ed\u671f\u4f7f\u7528\u30b9\u30c8\u30c3\u30af\uff1b\u672a\u958b\u5c01\u30d0\u30a4\u30a2\u30eb\u306e\u9577\u671f\u4fdd\u7ba1\u306f\u221220 \u00b0C\uff08\u221220 \u00b0C\u306736\u30f6\u6708\u4ee5\u4e0a\u5b89\u5b9a\uff09\u3002\u518d\u6eb6\u89e3\u5f8c\uff1a2\uff5e8 \u00b0C\u3001\u7d0430\u65e5\u4ee5\u5185\u306b\u4f7f\u7528\u3002\u9577\u6642\u9593\u306e\u5149\u66dd\u9732\u3092\u907f\u3051\u3066\u304f\u3060\u3055\u3044\u3002\u4f5c\u696d\u6eb6\u6db2\u306e\u7e70\u308a\u8fd4\u3057\u51cd\u7d50\u878d\u89e3\u306f\u907f\u3051\u3066\u304f\u3060\u3055\u3044\u3002<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>5-Amino-1MQ\u3068\u306f\u4f55\u3067\u3059\u304b\uff1f<\/h2>\n<p><strong>5-Amino-1MQ<\/strong> (5-\u30a2\u30df\u30ce-1-\u30e1\u30c1\u30eb\u30ad\u30ce\u30ea\u30cb\u30a6\u30e0 \u30e8\u30fc\u30b8\u30c9\u3001CAS 42464-96-0) \u306f\u3001\u4f4e\u5206\u5b50\u9078\u629e\u7684\u963b\u5bb3\u5264\u3067\u3042\u308a\u3001 <strong>\u30cb\u30b3\u30c1\u30f3\u30a2\u30df\u30c9 N-\u30e1\u30c1\u30eb\u30c8\u30e9\u30f3\u30b9\u30d5\u30a7\u30e9\u30fc\u30bc\uff08NNMT\uff09<\/strong>, \u3001\u7d30\u80de\u8cea\u306e\u30e1\u30c1\u30eb\u30c8\u30e9\u30f3\u30b9\u30d5\u30a7\u30e9\u30fc\u30bc\u9175\u7d20\u3067\u3042\u308a\u3001\u305d\u306e\u751f\u7269\u5b66\u306f\u904e\u53bb10\u5e74\u306b\u308f\u305f\u308a\u3001NAD<sup>+<\/sup>-\u8ef8\u4ee3\u8b1d\u3001\u8102\u80aa\u7d30\u80de\u306e\u8102\u80aa\u65b0\u751f\u3001\u7b4b\u5e79\u7d30\u80de\u751f\u7269\u5b66\u3001\u304a\u3088\u3073\u9593\u8cea\u304c\u3093\u4ee3\u8b1d\u3092\u3064\u306a\u3050\u30ce\u30fc\u30c9\u3068\u3057\u3066\u6d6e\u4e0a\u3057\u3066\u3044\u307e\u3059\u3002\u3053\u308c\u306f <em>\u30da\u30d7\u30c1\u30c9\u3067\u306f\u3042\u308a\u307e\u305b\u3093<\/em> \u2014 \u5408\u6210\u30ad\u30ce\u30ea\u30cb\u30a6\u30e0\u56db\u7d1a\u30a2\u30f3\u30e2\u30cb\u30a6\u30e0\u5869\u3067\u3042\u308a\u3001\u5206\u5b50\u5f0f\u306f C<sub>10<\/sub>H<sub>11<\/sub>IN<sub>2<\/sub> and a molecular weight of 286.11 g\/mol (as the iodide salt). MedsBase stocks it in the same lyophilized-vial format as our peptide catalogue for convenience of reconstitution and dosing in mixed-protocol studies. NNMT catalyses the transfer of a methyl group from <strong>S-\u30a2\u30c7\u30ce\u30b7\u30eb-L-\u30e1\u30c1\u30aa\u30cb\u30f3\uff08SAM\uff09<\/strong> \u2014 \u7d30\u80de\u5185\u306e\u666e\u904d\u7684\u306a\u30e1\u30c1\u30eb\u4f9b\u4e0e\u4f53 \u2014 \u306b\u3001 <strong>\u30cb\u30b3\u30c1\u30f3\u30a2\u30df\u30c9<\/strong>, \u30011-\u30e1\u30c1\u30eb\u30cb\u30b3\u30c1\u30f3\u30a2\u30df\u30c9\uff081-MNA\uff09\u304a\u3088\u3073S-\u30a2\u30c7\u30ce\u30b7\u30eb\u30db\u30e2\u30b7\u30b9\u30c6\u30a4\u30f3\uff08SAH\uff09\u3092\u751f\u6210\u3057\u307e\u3059\u3002\u3053\u306e\u53cd\u5fdc\u306f\u6700\u7d42\u7684\u306b\u4e21\u65b9\u306e\u57fa\u8cea\u3092\u6d88\u8cbb\u3057\u307e\u3059\uff1a\u30cb\u30b3\u30c1\u30f3\u30a2\u30df\u30c9\uff08\u901a\u5e38\u306fNAD\u306b\u518d\u30b5\u30eb\u30d9\u30fc\u30b8\u3055\u308c\u308b<sup>+<\/sup> NAMPT\u306b\u3088\u3063\u3066\uff09\u3001SAM\uff08\u901a\u5e38\u306f\u4ed6\u306e\u30e1\u30c1\u30eb\u30c8\u30e9\u30f3\u30b9\u30d5\u30a7\u30e9\u30fc\u30bc\u306b\u3088\u3063\u3066\u884c\u308f\u308c\u308b\u4f55\u767e\u3082\u306e\u7d30\u80de\u30e1\u30c1\u30eb\u5316\u53cd\u5fdc\u306b\u5229\u7528\u3055\u308c\u308b\uff09\u3067\u3059\u3002\u3057\u305f\u304c\u3063\u3066\u3001NNMT\u306f\u6700\u3082\u7814\u7a76\u3055\u308c\u3066\u3044\u308b2\u3064\u306e\u7d30\u80de\u751f\u5316\u5b66\u8ef8\u306e\u4ea4\u70b9\u306b\u4f4d\u7f6e\u3057\u3066\u3044\u307e\u3059 \u2014 \u3059\u306a\u308f\u3061NAD<sup>+<\/sup> salvage pathway and one-carbon \/ methylation metabolism \u2014 and its expression is markedly elevated in obesity-associated adipose tissue, cancer stroma, and aged skeletal muscle. 5-Amino-1MQ is the most-published <strong>\u4f4e\u5206\u5b50\u3001\u57fa\u8cea\u90e8\u4f4d\u6a19\u7684\u578b<\/strong> NNMT\u963b\u5bb3\u5264\u3067\u3059\u3002Neelakantan\u3089\uff082017\uff5e2018\u5e74\uff09\u306b\u3088\u308a\u30011.2 \u00b5M IC<sub>50<\/sub> \u7d44\u63db\u3048NNMT\u306b\u5bfe\u3057\u3066\u3001\u95a2\u9023\u30e1\u30c1\u30eb\u30c8\u30e9\u30f3\u30b9\u30d5\u30a7\u30e9\u30fc\u30bc\uff08GNMT\u3001PNMT\u3001COMT\uff09\u3084NAD<sup>+<\/sup>-salvage enzymes (NAMPT, NMNAT), and oral bioavailability sufficient to support in-vivo rodent dosing protocols. Subsequent in-vivo has documented activity in three independent disease-relevant model systems: diet-induced obesity, skeletal-muscle injury repair, and intraperitoneal ovarian-cancer metastasis \u2014 all without adverse effects up to 60\u00a0mg\/kg\/d. <\/p>\n<h2>\u4f5c\u7528\u6a5f\u5e8f \u2014 NNMT\u963b\u5bb3\u3068NAD<sup>+<\/sup>\/SAM\u8ef8<\/h2>\n<p>5-Amino-1MQ\u306e\u4f5c\u7528\u6a5f\u5e8f\u306f\u3001\u767a\u8868\u6587\u732e\u306e\u4e2d\u3067\u3042\u3089\u3086\u308b\u4f4e\u5206\u5b50NNMT\u963b\u5bb3\u5264\u306e\u4e2d\u3067\u6700\u3082\u89e3\u660e\u3055\u308c\u3066\u3044\u307e\u3059\uff1a<\/p>\n<ul>\n<li><strong>\u57fa\u8cea\u90e8\u4f4d\u306b\u304a\u3051\u308bNNMT\u306e\u7af6\u5408\u7684\u963b\u5bb3<\/strong> \u2014 5-Amino-1MQ\u306fNNMT\u306e\u30cb\u30b3\u30c1\u30f3\u30a2\u30df\u30c9\u57fa\u8cea\u30dd\u30b1\u30c3\u30c8\u306b\u7d50\u5408\u3057\u3001\u5929\u7136\u306e\u30cb\u30b3\u30c1\u30f3\u30a2\u30df\u30c9\u57fa\u8cea\u3068\u7af6\u5408\u3057\u3066SAM\u99c6\u52d5\u306e\u30e1\u30c1\u30eb\u57fa\u8ee2\u79fb\u3092\u963b\u5bb3\u3057\u307e\u3059\u30022018\u5e74\u306b\u516c\u958b\u3055\u308c\u305f\u5171\u7d50\u6676\u69cb\u9020\u306b\u3088\u308a\u3001\u57fa\u8cea\u30c1\u30e3\u30cd\u30eb\u306e\u76f4\u63a5\u7684\u5360\u6709\u304c\u78ba\u8a8d\u3055\u308c\u307e\u3057\u305f\u3002IC<sub>50<\/sub> = 1.2 \u00b5M\uff08\u751f\u7406\u5b66\u7684\u306b\u95a2\u9023\u3059\u308b\u88dc\u56e0\u5b50\u6fc3\u5ea6\uff1a50 \u00b5M SAM\u3001100 \u00b5M \u30cb\u30b3\u30c1\u30f3\u30a2\u30df\u30c9\uff09\u3002<\/li>\n<li><strong>NAD\u306e\u6e29\u5b58<sup>+<\/sup> \u524d\u99c6\u4f53\u30d7\u30fc\u30eb<\/strong> \u2014 NNMT\u306b\u3088\u3063\u3066\u30e1\u30c1\u30eb\u5316\u3055\u308c\u306a\u3044\u30cb\u30b3\u30c1\u30f3\u30a2\u30df\u30c9\u306f\u3001NAMPT-NMNAT\u30b5\u30eb\u30d9\u30fc\u30b8\u7d4c\u8def\u3067\u5229\u7528\u53ef\u80fd\u306a\u307e\u307e\u3068\u306a\u308a\u3001\u305d\u3053\u3067NMN\u306b\u5909\u63db\u3055\u308c\u3001\u305d\u306e\u5f8cNAD\u306b\u5909\u63db\u3055\u308c\u307e\u3059\u3002<sup>+<\/sup>. NNMT\u9ad8\u767a\u73fe\u7d30\u80de\u3067\u306fNAD<sup>+<\/sup> \u67af\u6e07\u304c\u3001\u516c\u8868\u3055\u308c\u305f\u7814\u7a76\u3067\u306f5-Amino-1MQ\u6cbb\u7642\u306b\u3088\u308a\u90e8\u5206\u7684\u306b\u9006\u8ee2\u3059\u308b\u3053\u3068\u304c\u5831\u544a\u3055\u308c\u3066\u304a\u308a\u3001\u3053\u308c\u306b\u3088\u308a\u672c\u5316\u5408\u7269\u306f\u6a5f\u69cb\u7684\u306bNAD<sup>+<\/sup> \u524d\u99c6\u4f53\uff08NMN\u3001NR\u3001\u30ca\u30a4\u30a2\u30b7\u30f3\u30a2\u30df\u30c9\uff09\u306f\u3001\u30cb\u30b3\u30c1\u30f3\u30a2\u30df\u30c9\u6d88\u8cbb\u901f\u5ea6\u3092\u4f4e\u4e0b\u3055\u305b\u308b\u306e\u3067\u306f\u306a\u304f\u3001\u4e0a\u6d41\u304b\u3089\u30d7\u30fc\u30eb\u306b\u8ffd\u52a0\u3059\u308b\u3082\u306e\u3067\u3059\u3002<\/li>\n<li><strong>SAM\u30d7\u30fc\u30eb\u7bc0\u7d04\u3068\u4e0b\u6d41\u30e1\u30c1\u30eb\u5316\u52b9\u679c<\/strong> \u2014 Each NNMT-catalysed reaction also consumes one SAM molecule, generating SAH. Inhibition of NNMT therefore raises intracellular SAM and lowers SAH, increasing the SAM:SAH ratio \u2014 the cellular methylation potential. This has been linked in published 3T3-L1 adipocyte studies to altered histone-methylation patterns at lipogenic gene loci and reduced de-novo lipogenesis.<\/li>\n<li><strong>1-\u30e1\u30c1\u30eb\u30cb\u30b3\u30c1\u30f3\u30a2\u30df\u30c9\uff081-MNA\uff09\u7523\u751f\u306e\u6e1b\u5c11<\/strong> \u2014 1-MNA is the immediate product of the NNMT reaction. In published studies, plasma and tissue 1-MNA falls rapidly after 5-Amino-1MQ administration, providing a convenient pharmacodynamic biomarker for target engagement in in-vivo work.<\/li>\n<li><strong>\u9078\u629e\u6027\u30d7\u30ed\u30d5\u30a1\u30a4\u30eb<\/strong> \u2014 5-Amino-1MQ\u306f\u3001\u95a2\u9023\u3059\u308b\u30e1\u30c1\u30eb\u57fa\u8ee2\u79fb\u9175\u7d20\u3067\u3042\u308bGNMT\uff08\u30b0\u30ea\u30b7\u30f3N-\u30e1\u30c1\u30eb\u30c8\u30e9\u30f3\u30b9\u30d5\u30a7\u30e9\u30fc\u30bc\uff09\u3001PNMT\uff08\u30d5\u30a7\u30cb\u30eb\u30a8\u30bf\u30ce\u30fc\u30eb\u30a2\u30df\u30f3N-\u30e1\u30c1\u30eb\u30c8\u30e9\u30f3\u30b9\u30d5\u30a7\u30e9\u30fc\u30bc\uff09\u3001\u307e\u305f\u306fCOMT\uff08\u30ab\u30c6\u30b3\u30fc\u30eb-O-\u30e1\u30c1\u30eb\u30c8\u30e9\u30f3\u30b9\u30d5\u30a7\u30e9\u30fc\u30bc\uff09\u3092\u963b\u5bb3\u305b\u305a\u3001\u307e\u305fNAD<sup>+<\/sup>\u30b5\u30eb\u30d9\u30fc\u30b8\u9175\u7d20\u3067\u3042\u308bNAMPT\u3084NMNAT\u3092\u59a8\u5bb3\u3057\u307e\u305b\u3093\u3002\u3053\u306e\u9078\u629e\u6027\u30d7\u30ed\u30d5\u30a1\u30a4\u30eb\u304c\u30015-Amino-1MQ\u3092\u5e83\u57df\u30b9\u30da\u30af\u30c8\u30e9\u30e0\u306e\u30e1\u30c1\u30eb\u57fa\u8ee2\u79fb\u9175\u7d20\u963b\u5bb3\u5264\u3068\u306f\u4e00\u7dda\u3092\u753b\u3057\u3001NNMT\u7279\u6709\u306e\u751f\u7269\u5b66\u3092\u89e3\u6790\u3059\u308b\u305f\u3081\u306e\u6a19\u6e96\u7684\u306a\u85ac\u7406\u5b66\u7684\u30c4\u30fc\u30eb\u3068\u3057\u3066\u3044\u307e\u3059\u3002<\/li>\n<\/ul>\n<p>The compound&#8217;s effects propagate from these biochemical primary actions into a small set of well-characterised cellular phenotypes: reduced 3T3-L1 adipocyte differentiation and lipogenesis (the most-cited in-vitro readout); increased muscle-satellite-cell proliferation and accelerated injury-repair in aged-mouse models; reduced peritoneal-tumour burden in ovarian-cancer metastasis models. Users should consult the primary literature (Neelakantan et\u00a0al. 2017\u20132019, Sampath et\u00a0al. 2018, subsequent NNMT-pathway reviews) for dose-response, kinetic, and species-specific parameters relevant to specific protocols. <\/p>\n<h2>Published Evidence<\/h2>\n<p>5-Amino-1MQ is used in clinical contexts that investigate:<\/p>\n<ul>\n<li><strong>NNMT\u8ef8\u306e\u751f\u5316\u5b66\u3068\u85ac\u7406\u5b66<\/strong> \u2014 \u7121\u7d30\u80de\u30a2\u30c3\u30bb\u30a4\u3001\u521d\u4ee3\u57f9\u990a\u7d30\u80de\u3001\u304a\u3088\u3073\u3052\u3063\u6b6f\u985e\u306ein vivo\u7814\u7a76\u306b\u304a\u3051\u308b\u9078\u629e\u7684NNMT\u963b\u5bb3\u306e\u305f\u3081\u306e\u6a19\u6e96\u7684\u306a\u85ac\u7406\u5b66\u7684\u30c4\u30fc\u30eb\u3067\u3042\u308a\u3001\u65b0\u898fNNMT\u963b\u5bb3\u5264\u9aa8\u683c\u306e\u4f5c\u7528\u6a5f\u5e8f\u7814\u7a76\u306e\u305f\u3081\u306e\u6a19\u6e96\u53c2\u7167\u5316\u5408\u7269\u3067\u3059\u3002<\/li>\n<li><strong>NAD<sup>+<\/sup>\u8ef8\u85ac\u7406\u5b66 \u2014 \u57fa\u8cea\u7bc0\u7d04\u30a2\u30d7\u30ed\u30fc\u30c1<\/strong> \u2014 NAD\u3068\u306f\u6a5f\u69cb\u7684\u306b\u7570\u306a\u308a\u307e\u3059<sup>+<\/sup>\u2014 \u524d\u99c6\u4f53\u30a2\u30d7\u30ed\u30fc\u30c1\uff08NMN\u3001NR\u3001\u30ca\u30a4\u30a2\u30b7\u30f3\u30a2\u30df\u30c9\u88dc\u7d66\uff09\u306f\u30d7\u30fc\u30eb\u3092\u4e0a\u304b\u3089\u5897\u3084\u3059\u306e\u306b\u5bfe\u3057\u30015-Amino-1MQ\u306f\u3080\u3057\u308dNAD\u3092\u6e1b\u5c11\u3055\u305b\u307e\u3059<sup>+<\/sup>\u2014 \u6700\u5927\u306e\u975e\u30b5\u30eb\u30d9\u30fc\u30b8\u53ef\u80fd\u306a\u30b7\u30f3\u30af\uff08NNMT\uff09\u3092\u906e\u65ad\u3059\u308b\u3053\u3068\u3067\u3001\u524d\u99c6\u4f53\u6d88\u8cbb\u3092\u4e0b\u304b\u3089\u6291\u5236\u3057\u307e\u3059<\/li>\n<li><strong>Adipocyte biology and obesity studies<\/strong> \u2014 \u98df\u4e8b\u8a98\u767a\u6027\u80a5\u6e80\u30de\u30a6\u30b9\u30e2\u30c7\u30eb\u3067\u5831\u544a\u3055\u308c\u305f20 mg\/kg\/\u65e5\u306e\u6295\u4e0e\u91cf\u306f\u3001\u8102\u80aa\u91cf\u306e\u6e1b\u5c11\u3001\u8010\u7cd6\u80fd\u306e\u6539\u5584\u3001\u809d\u81d3\u8102\u8cea\u84c4\u7a4d\u306e\u4f4e\u4e0b\u3092\u3082\u305f\u3089\u3059\u3068\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u307e\u305f\u3001\u6a19\u6e96\u7684\u306a3T3-L1\u5206\u5316\u30e2\u30c7\u30eb\u3067\u306f\u8102\u80aa\u5f62\u6210\u306e\u6e1b\u5c11\u304c\u793a\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/li>\n<li><strong>Skeletal-muscle stem-cell biology and ageing studies<\/strong> \u2014 \u30ab\u30eb\u30c7\u30a3\u30aa\u30c8\u30ad\u30b7\u30f3\u8a98\u767a\u6027\u7b4b\u640d\u50b7\u30de\u30a6\u30b9\u30e2\u30c7\u30eb\u3067\u5831\u544a\u3055\u308c\u305f5\uff5e10 mg\/kg\u306e\u6295\u4e0e\u91cf\u306f\u3001\u7279\u306bNNMT\u767a\u73fe\u304c\u4e0a\u6607\u3057\u3066\u3044\u308b\u9ad8\u9f62\u52d5\u7269\u306b\u304a\u3044\u3066\u3001\u885b\u661f\u7d30\u80de\u306e\u5897\u6b96\u3092\u52a0\u901f\u3057\u3001\u518d\u751f\u80fd\u3092\u6539\u5584\u3059\u308b\u3068\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/li>\n<li><strong>Cancer stromal-metabolism studies<\/strong> \u2014 5-Amino-1MQ has been used in published intraperitoneal HeyA8 ovarian-cancer-metastasis mouse models (up to 60\u00a0mg\/kg\/d) to reduce stromal NNMT activity and peritoneal tumour burden; also explored in stromal-targeted studies in pancreatic, prostate, and renal-cancer model systems where NNMT expression is high in the stromal compartment<\/li>\n<li><strong>Methylation-potential and one-carbon-metabolism studies<\/strong> \u2014 users studying the SAM:SAH ratio, global histone methylation, or DNA methylation can use 5-Amino-1MQ as a tool to perturb cellular methylation potential without directly inhibiting any DNA or histone methyltransferase<\/li>\n<li><strong>Mitochondrial bioenergetics combination studies<\/strong> \u2014 \u30d7\u30ed\u30c8\u30b3\u30eb\u3067\u306f\u30015-Amino-1MQ\uff08NAD<sup>+<\/sup>-\u524d\u99c6\u4f53\u6e29\u5b58\uff09\u3068 <a href=\"https:\/\/medsbase.com\/ja\/nad\/\">NAD<sup>+<\/sup><\/a> \uff08\u76f4\u63a5\u524d\u99c6\u4f53\u88dc\u5145\uff09\u307e\u305f\u306f <a href=\"https:\/\/medsbase.com\/ja\/ss-31-elamipretide\/\">SS-31<\/a> \uff08\u30ab\u30eb\u30b8\u30aa\u30ea\u30d4\u30f3\u7d50\u5408\u6027\u30df\u30c8\u30b3\u30f3\u30c9\u30ea\u30a2\u6a19\u7684\u30da\u30d7\u30c1\u30c9\uff09\u3092\u7528\u3044\u3066\u3001\u4e0a\u6d41\u57fa\u8cea\u3068\u4e0b\u6d41\u96fb\u5b50\u30d5\u30e9\u30c3\u30af\u30b9\u306e\u30df\u30c8\u30b3\u30f3\u30c9\u30ea\u30a2\u751f\u4f53\u30a8\u30cd\u30eb\u30ae\u30fc\u51fa\u529b\u3078\u306e\u5bc4\u4e0e\u3092\u8abf\u3079\u308b<\/li>\n<\/ul>\n<p>NAD\u306b\u95a2\u3059\u308b\u3088\u308a\u5e83\u7bc4\u306a\u80cc\u666f\u306b\u3064\u3044\u3066\u306f\u3001<sup>+<\/sup>-axis and mitochondrial \/ metabolic support compounds in this catalogue, see <a href=\"https:\/\/medsbase.com\/ja\/nad\/\">NAD<sup>+<\/sup><\/a> \uff08\u9178\u5316\u578b\u30b8\u30cc\u30af\u30ec\u30aa\u30c1\u30c9\u88dc\u9175\u7d20\u3001\u96fb\u5b50\u4f1d\u9054\u7cfb\u306e\u4e2d\u5fc3\u7684\u57fa\u8cea\uff09\u3001, <a href=\"https:\/\/medsbase.com\/ja\/mots-c\/\">MOTS-c<\/a> \uff08\u30df\u30c8\u30b3\u30f3\u30c9\u30ea\u30a2\u7531\u6765\u4ee3\u8b1d\u8abf\u7bc0\u30da\u30d7\u30c1\u30c9\uff09\u3001, <a href=\"https:\/\/medsbase.com\/ja\/ss-31-elamipretide\/\">SS-31 (Elamipretide)<\/a> \uff08\u30df\u30c8\u30b3\u30f3\u30c9\u30ea\u30a2\u6a19\u7684\u578b\u30ab\u30eb\u30b8\u30aa\u30ea\u30d4\u30f3\u7d50\u5408\u30da\u30d7\u30c1\u30c9\uff09\u3001\u304a\u3088\u3073 <a href=\"https:\/\/medsbase.com\/ja\/l-carnitine\/\">L-\u30ab\u30eb\u30cb\u30c1\u30f3<\/a> \uff08\u30df\u30c8\u30b3\u30f3\u30c9\u30ea\u30a2\u9577\u9396\u8102\u80aa\u9178\u30b7\u30e3\u30c8\u30eb\uff09\u3002\u5168 <a href=\"https:\/\/medsbase.com\/ja\/peptides\/\">peptides &amp; compounds catalog<\/a> \u95a2\u9023\u5316\u5408\u7269\u306b\u3064\u3044\u3066\u306f\u3001\u3042\u308b\u3044\u306f\u53b3\u9078\u3055\u308c\u305f <a href=\"https:\/\/medsbase.com\/ja\/best-longevity-peptides\/\">longevity compounds<\/a> KYC\uff08Know Your Customer\uff09 <a href=\"https:\/\/medsbase.com\/ja\/best-peptides-for-fat-loss\/\">fat-loss peptides<\/a> \u30cf\u30d6\u3002 <\/p>\n<h2>\u5229\u7528\u53ef\u80fd\u306a\u529b\u4fa1\u3068\u6fc3\u5ea6<\/h2>\n<p>MedsBase stocks 5-Amino-1MQ in three lyophilized vial sizes calibrated to typical protocol lengths. Each strength is available in 10-vial, 20-vial, or 30-vial pack formats:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">\u30d0\u30a4\u30a2\u30eb\u529b\u4fa1<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">\u4ee3\u8868\u7684\u306a\u4f7f\u7528\u4f8b<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">\u30d1\u30c3\u30af\u30b5\u30a4\u30ba<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>5 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">in vitro\u7d30\u80de\u57f9\u990a\u304a\u3088\u3073\u77ed\u671fin vivo\u6ef4\u5b9a \u2014 3T3-L1\u5206\u5316\u30a2\u30c3\u30bb\u30a4\u3001\u521d\u4ee3\u7d30\u80de\u85ac\u7406\u5b66\u3001\u5358\u4e00\u30b3\u30db\u30fc\u30c8\u7528\u91cf\u53cd\u5fdc\u8a66\u9a13<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10\u300120\u3001\u307e\u305f\u306f30\u30d0\u30a4\u30a2\u30eb<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>10 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u6a19\u6e96\u7684\u306a\u4e2d\u7528\u91cf \u2014 \u98df\u4e8b\u8a98\u767a\u6027\u80a5\u6e80\u3052\u3063\u6b6f\u985ein vivo\u30d7\u30ed\u30c8\u30b3\u30fc\u30eb\uff0820 mg\/kg\/\u65e5\u30014\uff5e8\u9031\u9593\uff09\u3001\u7b4b\u640d\u50b7\u518d\u751f\u306e\u7d4c\u6642\u7684\u7814\u7a76\u3001\u4e2d\u898f\u6a21\u30b3\u30db\u30fc\u30c8\u306e\u30b5\u30f3\u30d7\u30eb\u30b5\u30a4\u30ba<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10\u300120\u3001\u307e\u305f\u306f30\u30d0\u30a4\u30a2\u30eb<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>50 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">High-throughput \/ extended-cycle protocols \u2014 large-cohort metabolic studies, multi-arm cancer-stroma studies (up to 60\u00a0mg\/kg\/d in HeyA8 ovarian-cancer model), long-arm chronic-dosing work; lowest per-mg cost<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10\u300120\u3001\u307e\u305f\u306f30\u30d0\u30a4\u30a2\u30eb<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>All three strengths are the same chemical entity (lyophilized 5-amino-1-methylquinolinium iodide, \u226599% HPLC purity). The 50\u00a0mg vial provides the lowest per-mg cost for large in-vivo protocols (a single 50\u00a0mg vial covers roughly two weeks of 20\u00a0mg\/kg\/d dosing in a 20-g mouse, or about three days at 60\u00a0mg\/kg\/d in a 30-g rat). Users should determine specific dose ranges from peer-reviewed literature appropriate to the protocol. <\/p>\n<h2>\u6bd4\u8f03\uff1a5-Amino-1MQ\u3068NAD<sup>+<\/sup><\/h2>\n<p>5-Amino-1MQ\u3068 <a href=\"https:\/\/medsbase.com\/ja\/nad\/\">NAD<sup>+<\/sup><\/a> are both NAD-axis compounds, but they intervene at completely different points of the same metabolic loop. NAD<sup>+<\/sup> \u30b8\u30cc\u30af\u30ec\u30aa\u30c1\u30c9\u30d7\u30fc\u30eb\u3092\u76f4\u63a5\u88dc\u5145\u3057\u3001\u4e0b\u6d41\u306e\u9178\u5316\u9084\u5143\uff0f\u30b5\u30fc\u30c1\u30e5\u30a4\u30f3\uff0fPARP\u57fa\u8cea\u306e\u53ef\u7528\u6027\u3092\u9ad8\u3081\u308b\u3053\u3068\u3092\u76ee\u7684\u3068\u3059\u308b\u5834\u5408\u306b\u6709\u7528\u3067\u3059\u30025-Amino-1MQ\u306fNNMT\u89e6\u5a92\u306b\u3088\u308b\u30cb\u30b3\u30c1\u30f3\u30a2\u30df\u30c9\u306e\u6700\u7d42\u6d88\u8cbb\u3092\u963b\u5bb3\u3057\u3001NAD\u306e\u67af\u6e07\u3092\u9045\u3089\u305b\u308b\u3053\u3068\u3092\u76ee\u7684\u3068\u3059\u308b\u5834\u5408\u306b\u6709\u7528\u3067\u3059\u3002<sup>+<\/sup> precursor pool from cellular methylation-axis crosstalk. The two compounds are mechanistically complementary, and protocols sometimes combine them to dissect upstream-substrate (NAD<sup>+<\/sup>) \u5bfe \u4e0b\u6d41\u524d\u99c6\u4f53\u6e29\u5b58\uff085-Amino-1MQ\uff09\u306eNAD\u8ef8\u51fa\u529b\u3078\u306e\u5bc4\u4e0e\u3002 <\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">\u8a55\u4fa1\u9805\u76ee<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">5-Amino-1MQ<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">NAD<sup>+<\/sup><\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>\u5316\u5b66\u5206\u985e<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u4f4e\u5206\u5b50\u30ad\u30ce\u30ea\u30cb\u30a6\u30e0\u7b2c\u56db\u7d1a\u30a2\u30f3\u30e2\u30cb\u30a6\u30e0\u5869<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u30b8\u30cc\u30af\u30ec\u30aa\u30c1\u30c9\u88dc\u9175\u7d20\uff08\u30a2\u30c7\u30cb\u30f3\u3068\u30cb\u30b3\u30c1\u30f3\u30a2\u30df\u30c9\u30cc\u30af\u30ec\u30aa\u30c1\u30c9\u304c\u4e8c\u30ea\u30f3\u9178\u3092\u4ecb\u3057\u3066\u7d50\u5408\uff09<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>\u5206\u5b50\u91cf<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">286.11 g\/mol<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">663.43 g\/mol<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>NAD\u8ef8\u306b\u304a\u3051\u308b\u4ecb\u5165\u70b9<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">NNMT\u306b\u3088\u308b\u30cb\u30b3\u30c1\u30f3\u30a2\u30df\u30c9\u6d88\u8cbb\u3092\u963b\u5bb3\uff08\u4e0b\u6d41\u304b\u3089\u306e\u524d\u99c6\u4f53\u67af\u6e07\u3092\u9045\u5ef6\uff09<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u30b8\u30cc\u30af\u30ec\u30aa\u30c1\u30c9\u30d7\u30fc\u30eb\u306b\u76f4\u63a5\u8ffd\u52a0\uff08\u4e0a\u6d41\u304b\u3089\u57fa\u8cea\u3092\u5897\u52a0\uff09<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Best-studied studies focus<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u8102\u80aa\u7d30\u80de\u306e\u8102\u80aa\u751f\u6210\u3001\u7b4b\u885b\u661f\u7d30\u80de\u306e\u4fee\u5fa9\u3001\u764c\u9593\u8cea\u4ee3\u8b1d\u3001NNMT\u8ef8\u85ac\u7406\u5b66<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u30b5\u30fc\u30c1\u30e5\u30a4\u30f3\u751f\u7269\u5b66\u3001\u9577\u5bff\u3001\u7d30\u80de\u8001\u5316\u3001NAD\u8ef8\u306e\u9178\u5316\u9084\u5143\u8abf\u7bc0<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>\u9078\u629e\u6027<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u9ad8\u3044 \u2014 GNMT\u3001PNMT\u3001COMT\u3001NAMPT\u3001NMNAT\u3092\u963b\u5bb3\u3057\u306a\u3044<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u8a72\u5f53\u306a\u3057\uff08NAD<sup>+<\/sup> \u304c\u5929\u7136\u306e\u57fa\u8cea\u3067\u3042\u308b\uff09<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>\u8840\u6f3f\u4e2d\u5b89\u5b9a\u6027<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u5b89\u5b9a \u2014 \u534a\u6e1b\u671f\u306f\u6570\u6642\u9593\uff1b\u7d4c\u53e3\u3001\u8179\u8154\u5185\u3001\u9759\u8108\u5185\u6295\u4e0e\u306b\u5bfe\u5fdc<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u4e0d\u5b89\u5b9a \u2014 \u6eb6\u6db2\u4e2d\u3067\u306e\u534a\u6e1b\u671f\u306f\u6570\u5206\uff1b\u6025\u901f\u306b\u9178\u5316\u30fb\u5206\u89e3\u3059\u308b<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>\u4e00\u822c\u7684\u306a\u7528\u91cf<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u516c\u8868\u30de\u30a6\u30b9\u30d7\u30ed\u30c8\u30b3\u30eb\u3067\u306f5\uff5e60 mg\/kg\/\u65e5\uff08DIO\u3067\u306f20 mg\/kg\/\u65e5\u304c\u6700\u3082\u4e00\u822c\u7684\uff1b\u6709\u5bb3\u4f5c\u7528\u306a\u3057\u3067\u8a66\u9a13\u3055\u308c\u305f\u6700\u9ad8\u7528\u91cf\u306f60 mg\/kg\/\u65e5\uff09<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u6570\u5341\u304b\u3089\u6570\u767emg\uff08\u7d30\u80de\u57f9\u990a\uff1a\u00b5M\u6fc3\u5ea6\uff09<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>FDA\u627f\u8a8d<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">No \u2014 compound only<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">No \u2014 compound only<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>For studies focused on NAD<sup>+<\/sup>-axis precursor consumption by NNMT, adipocyte lipogenesis, or muscle-stem-cell biology, 5-Amino-1MQ is the canonical pharmacological tool. For studies focused on direct NAD<sup>+<\/sup>\u30d7\u30fc\u30eb\u88dc\u5145\u3001\u30b5\u30fc\u30c1\u30e5\u30a4\u30f3\u751f\u7269\u5b66\u3001\u307e\u305f\u306fNAD\u4f9d\u5b58\u6027\u306e\u9178\u5316\u9084\u5143\u8abf\u7bc0\u306b\u7126\u70b9\u3092\u5f53\u3066\u305f\u7814\u7a76\u3067\u306f\u3001, <a href=\"https:\/\/medsbase.com\/ja\/nad\/\">NAD<sup>+<\/sup><\/a> \u306f\u3088\u308a\u6a19\u7684\u3092\u7d5e\u3063\u305f\u5316\u5408\u7269\u3067\u3059\u3002\u3053\u3061\u3089\u3082\u3054\u89a7\u304f\u3060\u3055\u3044 <a href=\"https:\/\/medsbase.com\/ja\/mots-c\/\">MOTS-c<\/a> for mitochondrial-derived peptide-signalling studies and <a href=\"https:\/\/medsbase.com\/ja\/ss-31-elamipretide\/\">SS-31 (Elamipretide)<\/a> for cardiolipin-binding mitochondrial-targeted studies. <\/p>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 14px 18px; margin: 18px 0;\"><strong class=\"mb-bac-water-callout\">\ud83d\udca7 BAC\u6c34\u304c\u5fc5\u8981\u3067\u3059\u304b\uff1f<\/strong> \u51cd\u7d50\u4e7e\u71e5\u54c1\u306e\u5fa9\u5143\u306b\u306f\u6ec5\u83cc\u9759\u83cc\u6c34\u304c\u5fc5\u8981\u3067\u3059\u3002\u672c\u88fd\u54c1\u3068\u4f75\u305b\u3066\u5f53\u793e\u306e <a href=\"\/ja\/bac-water\/\"><strong>BAC Water\uff08\u9759\u83cc\u6c34\uff09<\/strong><\/a> \u2014 30 mL\u30de\u30eb\u30c1\u30c9\u30fc\u30ba\u30d0\u30a4\u30a2\u30eb\u30010.9%\u30d9\u30f3\u30b8\u30eb\u30a2\u30eb\u30b3\u30fc\u30eb\u4fdd\u5b58\u3001USP\u30b0\u30ec\u30fc\u30c9\u3002<\/div>\n<h2>\u4fdd\u7ba1\u65b9\u6cd5\u3068\u518d\u6eb6\u89e3<\/h2>\n<p><strong>\u518d\u6eb6\u89e3\u524d\uff1a<\/strong> \u77ed\u671f\u4f7f\u7528\u306e\u30ef\u30fc\u30ad\u30f3\u30b0\u30b9\u30c8\u30c3\u30af\u3068\u3057\u3066\u3001\u51cd\u7d50\u4e7e\u71e5\u30d0\u30a4\u30a2\u30eb\u306f2\uff5e8 \u00b0C\u306e\u51b7\u8535\u3067\u3001\u5143\u306e\u5305\u88c5\u306e\u307e\u307e\u4fdd\u7ba1\u3057\u3066\u304f\u3060\u3055\u3044\u3002\u9577\u671f\u4fdd\u5b58\u306e\u5834\u5408\u306f\u3001\u672a\u958b\u5c01\u306e\u30d0\u30a4\u30a2\u30eb\u3092\u221220 \u00b0C\u3067\u51cd\u7d50\u4fdd\u5b58\u3057\u3066\u304f\u3060\u3055\u3044\uff08\u221220 \u00b0C\u3067\u6700\u4f4e36\u304b\u6708\u9593\u5b89\u5b9a\u30012\uff5e8 \u00b0C\u3067\u6700\u4f4e12\u304b\u6708\u9593\u5b89\u5b9a\uff09\u3002\u51cd\u7d50\u4e7e\u71e55-Amino-1MQ\u306f\u3001\u5c0f\u5206\u5b50\u30ad\u30ce\u30ea\u30cb\u30a6\u30e0\u5869\u69cb\u9020\u306b\u306f\u52a0\u6c34\u5206\u89e3\u3055\u308c\u308b\u30a2\u30df\u30c9\u7d50\u5408\u3084\u30b8\u30b9\u30eb\u30d5\u30a3\u30c9\u67b6\u6a4b\u304c\u306a\u3044\u305f\u3081\u3001\u307b\u3068\u3093\u3069\u306e\u51cd\u7d50\u4e7e\u71e5\u30da\u30d7\u30c1\u30c9\u3088\u308a\u3082\u5927\u5e45\u306b\u5b89\u5b9a\u3057\u3066\u3044\u307e\u3059\u3002\u76f4\u5c04\u65e5\u5149\u306b\u9577\u6642\u9593\u3055\u3089\u3055\u306a\u3044\u3088\u3046\u4fdd\u8b77\u3057\u3066\u304f\u3060\u3055\u3044\u3002 <strong>\u518d\u6eb6\u89e3\u624b\u9806\uff1a<\/strong> \u9759\u83cc\u6c34\u3001\u6ec5\u83cc\u6c34\u3001\u307e\u305f\u306f\u6ec5\u83ccPBS\u3092\u30d0\u30a4\u30a2\u30eb\u306e\u5074\u58c1\u306b\u6cbf\u3063\u3066\u6ce8\u5165\u3057\u3066\u304f\u3060\u3055\u3044\uff08\u51cd\u7d50\u4e7e\u71e5\u30b1\u30fc\u30ad\u306b\u76f4\u63a5\u304b\u3051\u306a\u3044\u3067\u304f\u3060\u3055\u3044\uff09\u30025 mg\u30d0\u30a4\u30a2\u30eb\u306e\u5834\u5408\u3001\u5e0c\u91c8\u6db21.0 mL\u30675 mg\/mL\u306e\u4f5c\u696d\u6fc3\u5ea6\u304c\u5f97\u3089\u308c\u30010.5 mL\u3067\u306f10 mg\/mL\u306b\u306a\u308a\u307e\u3059\u300210 mg\u30d0\u30a4\u30a2\u30eb\u306e\u5834\u5408\u30011.0 mL\u306710 mg\/mL\u30012.0 mL\u30675 mg\/mL\u306b\u306a\u308a\u307e\u3059\u300250 mg\u30d0\u30a4\u30a2\u30eb\u306e\u5834\u5408\u30011.0 mL\u306750 mg\/mL\uff08\u6c34\u6027\u30d0\u30c3\u30d5\u30a1\u30fc\u4e2d\u3067\u306e\u5b9f\u7528\u7684\u6eb6\u89e3\u9650\u5ea6\uff09\u30015.0 mL\u3067\u3088\u308a\u5e0c\u8584\u306a10 mg\/mL\u306e\u30ef\u30fc\u30ad\u30f3\u30b0\u30b9\u30c8\u30c3\u30af\u304c\u5f97\u3089\u308c\u307e\u3059\u30025-Amino-1MQ\u306f\u3001\u7a4f\u3084\u304b\u306b\u65cb\u56de\u3055\u305b\u308b\u3060\u3051\u3067\u975e\u5e38\u306b\u901f\u304f\u6eb6\u89e3\u3057\u307e\u3059\uff08\u901a\u5e3810\uff5e30\u79d2\u4ee5\u5185\uff09\u3002\u3053\u308c\u306f\u3001\u7b2c\u56db\u7d1a\u30a2\u30f3\u30e2\u30cb\u30a6\u30e0\u5869\u304c\u975e\u5e38\u306b\u89aa\u6c34\u6027\u304c\u9ad8\u304f\u3001\u6298\u308a\u7573\u307e\u308c\u305f\u69cb\u9020\u304c\u306a\u3044\u305f\u3081\u3067\u3059\u3002in vitro\u7d30\u80de\u57f9\u990a\u4f5c\u696d\u3067\u306f\u3001DMSO\u3082\u9069\u5207\u306a\u518d\u69cb\u6210\u6eb6\u5a92\u3067\u3059\uff08\u6700\u5927100 mM\u306e\u30b9\u30c8\u30c3\u30af\u3092\u4f5c\u6210\u53ef\u80fd\uff09\u3002\u4f7f\u7528\u76f4\u524d\u306b\u6c34\u6027\u57f9\u5730\u306b\u4f5c\u696d\u6eb6\u6db2\u3092\u5e0c\u91c8\u3057\u3066\u304f\u3060\u3055\u3044\u3002\u6c34\u6027\u30d0\u30c3\u30d5\u30a1\u30fc\u3067\u518d\u69cb\u6210\u5f8c\u306f\u3001\u30d0\u30a4\u30a2\u30eb\u30922\uff5e8 \u00b0C\u3067\u4fdd\u7ba1\u3057\u300130\u65e5\u4ee5\u5185\u306b\u4f7f\u7528\u3057\u3066\u304f\u3060\u3055\u3044\u3002\u5149\u304b\u3089\u4fdd\u8b77\u3057\u3066\u304f\u3060\u3055\u3044\u3002\u6fc1\u308a\u3001\u7c92\u5b50\u72b6\u7269\u8cea\u3001\u307e\u305f\u306f\u9855\u8457\u306a\u8272\u306e\u5909\u5316\u304c\u898b\u3089\u308c\u308b\u5834\u5408\u306f\u5ec3\u68c4\u3057\u3066\u304f\u3060\u3055\u3044\u3002 <\/p>\n<h2>\u3088\u304f\u3042\u308b\u8cea\u554f<\/h2>\n<h3>5-Amino-1MQ\u306f\u30da\u30d7\u30c1\u30c9\u3067\u3059\u304b\uff1f<\/h3>\n<p>\u3044\u3044\u3048\u30025-Amino-1MQ\u306f\u3001\u5c0f\u5206\u5b50\u30ad\u30ce\u30ea\u30cb\u30a6\u30e0\u7b2c\u56db\u7d1a\u30a2\u30f3\u30e2\u30cb\u30a6\u30e0\u5869\uff08\u30e8\u30a6\u5316\u7269\u3068\u3057\u3066\u5206\u5b50\u91cf286.11 g\/mol\uff09\u3067\u3042\u308a\u3001, <em>\u3057\u307e\u305b\u3093<\/em> a peptide. We stock it in our studies-peptide catalogue alongside <a href=\"https:\/\/medsbase.com\/ja\/nad\/\">NAD<sup>+<\/sup><\/a> KYC\uff08Know Your Customer\uff09 <a href=\"https:\/\/medsbase.com\/ja\/l-carnitine\/\">L-\u30ab\u30eb\u30cb\u30c1\u30f3<\/a> because it serves a complementary role in mitochondrial \/ metabolic \/ NAD-axis studies and is supplied in the same lyophilized vial format. The spec table Sequence row is marked &#8220;n\/a&#8221; for this reason. <\/p>\n<h3>NNMT\u963b\u5bb3\u306f\u5b9f\u969b\u306b\u7d30\u80de\u5185\u3067\u4f55\u3092\u3059\u308b\u306e\u3067\u3059\u304b\uff1f<\/h3>\n<p>NNMT\uff08\u30cb\u30b3\u30c1\u30f3\u30a2\u30df\u30c9N-\u30e1\u30c1\u30eb\u30c8\u30e9\u30f3\u30b9\u30d5\u30a7\u30e9\u30fc\u30bc\uff09\u306f\u3001\u30cb\u30b3\u30c1\u30f3\u30a2\u30df\u30c9\uff08NAD<sup>+<\/sup>\u524d\u99c6\u4f53\u306e\u5229\u7528\u53ef\u80fd\u6027\u304c\u4e0a\u6607\u3057\u307e\u3059\uff08\u30cb\u30b3\u30c1\u30f3\u30a2\u30df\u30c9\u304cNAMPT-NMNAT\u306b\u3088\u308b\u30b5\u30eb\u30d9\u30fc\u30b8\u7d4c\u8def\u3067NMN\u3068NAD<sup>+<\/sup> \uff09\u3001\u305d\u3057\u3066\u7d30\u80de\u5185SAM\u304c\u4e0a\u6607\u3057\u3001SAH\u304c\u4f4e\u4e0b\u3057\u307e\u3059\uff08\u3053\u308c\u306b\u3088\u308a\u7d30\u80de\u306e\u30e1\u30c1\u30eb\u5316\u30dd\u30c6\u30f3\u30b7\u30e3\u30eb\u3001\u3059\u306a\u308f\u3061SAM:SAH\u6bd4\u304c\u4e0a\u6607\u3057\u307e\u3059\uff09\u3002\u3053\u308c\u3089\u306e2\u3064\u306e\u751f\u5316\u5b66\u7684\u4e00\u6b21\u52b9\u679c\u306f\u3001\u516c\u8868\u3055\u308c\u305f\u7814\u7a76\u3067\u5b9f\u8a3c\u3055\u308c\u305f\u7d30\u80de\u8868\u73fe\u578b\u3078\u3068\u3064\u306a\u304c\u308a\u307e\u3059\uff1a\u8102\u80aa\u7d30\u80de\u306e\u8102\u8cea\u751f\u6210\u306e\u6e1b\u5c11\u3001\u7b4b\u5e79\u7d30\u80de\u4fee\u5fa9\u306e\u4fc3\u9032\u3001\u305d\u3057\u3066\u304c\u3093\u9593\u8cea\u306e\u816b\u760d\u652f\u6301\u4ee3\u8b1d\u306e\u4f4e\u6e1b\u3067\u3059\u3002<sup>+<\/sup>), and intracellular SAM rises while SAH falls (raising the cellular methylation potential \u2014 the SAM:SAH ratio). These two biochemical primary effects propagate into the cellular phenotypes documented in published studies: reduced adipocyte lipogenesis, accelerated muscle-stem-cell repair, and reduced cancer-stroma tumour-supportive metabolism. <\/p>\n<h3>5-Amino-1MQ\u306fNMN\u3001NR\u3001\u30ca\u30a4\u30a2\u30b7\u30f3\u30a2\u30df\u30c9\u3068\u3069\u306e\u3088\u3046\u306b\u7570\u306a\u308a\u307e\u3059\u304b\uff1f<\/h3>\n<p>NMN, NR, and niacinamide are all NAD<sup>+<\/sup>-\u524d\u99c6\u4f53\u5316\u5408\u7269 \u2014 \u3053\u308c\u3089\u306fNAD<sup>+<\/sup> pool from above by supplying salvageable precursors. 5-Amino-1MQ does the opposite: it blocks the terminal consumption of nicotinamide by NNMT, sparing the precursor pool from below. Mechanistically, the two approaches are complementary \u2014 published combination has explored whether co-administration of a precursor (NMN or NR) with a sparing agent (5-Amino-1MQ) produces an additive or super-additive effect on NAD<sup>+<\/sup> \u306e\u30ec\u30d9\u30eb\u306b\u53ca\u307c\u3059\u52b9\u679c\u304c\u5404\u4ecb\u5165\u5358\u72ec\u3068\u6bd4\u8f03\u3057\u3066\u76f8\u52a0\u7684\u307e\u305f\u306f\u8d85\u76f8\u52a0\u7684\u3067\u3042\u308b\u304b\u3069\u3046\u304b\u304c\u691c\u8a0e\u3055\u308c\u307e\u3057\u305f\u3002 <\/p>\n<h3>What published dose ranges have been used in mouse studies?<\/h3>\n<p>The most-cited mouse-protocol dose is 20\u00a0mg\/kg\/d for diet-induced obesity studies (4\u20138 weeks of daily intraperitoneal or oral administration). The injury-repair muscle has used 5\u201310\u00a0mg\/kg. The HeyA8 ovarian-cancer-metastasis has used up to 60\u00a0mg\/kg\/d without adverse effects reported in the published studies. Users should consult primary literature (Neelakantan et\u00a0al. 2017\u20132019, Sampath et\u00a0al. 2018, subsequent NNMT-pathway reviews) for species-, model-, and endpoint-specific dosing guidance. <\/p>\n<h3>What routes of administration are used in published studies?<\/h3>\n<p>Intraperitoneal (IP) administration in rodents is the most-common route in published in-vivo studies because it provides reliable systemic exposure and is convenient for repeated daily dosing. Oral administration (gavage or drinking water) has also been used in chronic dosing protocols. Subcutaneous and intravenous routes are less common but are documented. For in-vitro work, the compound is added directly to culture medium at micromolar concentrations. <\/p>\n<h3>5-Amino-1MQ\u306fNAD<sup>+<\/sup>, MOTS-c, or SS-31 in protocols?<\/h3>\n<p>Yes \u2014 the four compounds target different layers of mitochondrial and NAD-axis biology and are commonly combined in studies that aims to dissect upstream-substrate vs downstream-electron-flux vs cardiolipin \/ inner-membrane structural contributions to mitochondrial output. They are chemically stable in solution together. Reconstitute each separately first to establish stability and concentration accuracy, then combine immediately before use rather than co-storing reconstituted vials. The most-studied combination in published literature is 5-Amino-1MQ with NAD<sup>+<\/sup> \u524d\u8ff0\u306e\u524d\u99c6\u4f53\uff08NMN\u307e\u305f\u306fNR\uff09; \u30da\u30d7\u30c1\u30c9\u5316\u5408\u7269\u3068\u306e\u7d44\u307f\u5408\u308f\u305b\u306f\u767a\u8868\u304c\u5c11\u306a\u3044\u3082\u306e\u306e\u3001\u6a5f\u69cb\u7684\u306b\u306f\u5408\u7406\u7684\u3067\u3059\u3002 <\/p>\n<h3>5-Amino-1MQ\u304cFDA\u627f\u8a8d\u3055\u308c\u3066\u3044\u306a\u3044\u306e\u306f\u306a\u305c\u3067\u3059\u304b\uff1f<\/h3>\n<p>5-Amino-1MQ is a relatively recent tool compound (substrate-site selectivity was first published by Neelakantan et\u00a0al. in 2017) and has not entered human clinical development to date. The NNMT-inhibitor space is active in early-stage drug discovery \u2014 several second-generation NNMT inhibitor scaffolds are in preclinical development \u2014 but no compound in this class has yet completed human clinical trials. 5-Amino-1MQ remains the most-published reference tool for selective NNMT inhibition in clinical studies. <\/p>\n<h3>5-Amino-1MQ\u306e\u9078\u629e\u6027\u306f\u3001\u3088\u308a\u5e83\u7bc4\u306a\u30b9\u30da\u30af\u30c8\u30eb\u306e\u30e1\u30c1\u30eb\u30c8\u30e9\u30f3\u30b9\u30d5\u30a7\u30e9\u30fc\u30bc\u963b\u5bb3\u5264\u3068\u3069\u306e\u3088\u3046\u306b\u6bd4\u8f03\u3055\u308c\u307e\u3059\u304b\uff1f<\/h3>\n<p>5-Amino-1MQ\u306f\u57fa\u8cea\u90e8\u4f4d\u3092\u6a19\u7684\u3068\u3057\u305f\u963b\u5bb3\u5264\u3067\u3001NNMT\u306e\u30cb\u30b3\u30c1\u30f3\u30a2\u30df\u30c9\u57fa\u8cea\u30dd\u30b1\u30c3\u30c8\u306b\u7d50\u5408\u3057\u3001SAM\u88dc\u56e0\u5b50\u30dd\u30b1\u30c3\u30c8\u306b\u306f\u95a2\u4e0e\u3057\u307e\u305b\u3093\u3002\u3053\u308c\u306fSAM\u7af6\u5408\u578b\u30e1\u30c1\u30eb\u30c8\u30e9\u30f3\u30b9\u30d5\u30a7\u30e9\u30fc\u30bc\u963b\u5bb3\u5264\uff08\u30b7\u30cd\u30d5\u30a1\u30f3\u30ae\u30f3\u3084\u30e1\u30c1\u30eb\u30c1\u30aa\u30a2\u30c7\u30ce\u30b7\u30f3\u985e\u4f3c\u4f53\u306a\u3069\uff09\u3068\u306f\u6a5f\u69cb\u7684\u306b\u7570\u306a\u308a\u3001\u3053\u308c\u3089\u306f\u88dc\u56e0\u5b50\u30dd\u30b1\u30c3\u30c8\u3092\u6a19\u7684\u3068\u3059\u308b\u305f\u3081\u3001\u5e83\u7bc4\u56f2\u306e\u30e1\u30c1\u30eb\u30c8\u30e9\u30f3\u30b9\u30d5\u30a7\u30e9\u30fc\u30bc\u3092\u963b\u5bb3\u3057\u307e\u3059\u3002\u57fa\u8cea\u90e8\u4f4d\u3092\u6a19\u7684\u3068\u3059\u308b\u30a2\u30d7\u30ed\u30fc\u30c1\u306b\u3088\u308a\u30015-Amino-1MQ\u306fGNMT\u3001PNMT\u3001COMT\u306a\u3069\u306e\u4ed6\u306eSAM\u4f9d\u5b58\u6027\u9175\u7d20\u306b\u5bfe\u3057\u3066\u9078\u629e\u6027\u3092\u793a\u3057\u3001\u6c4e\u30e1\u30c1\u30eb\u30c8\u30e9\u30f3\u30b9\u30d5\u30a7\u30e9\u30fc\u30bc\u963b\u5bb3\u5264\u3068\u3057\u3066\u3067\u306f\u306a\u304f\u3001NNMT\u7279\u7570\u7684\u306a\u751f\u7269\u5b66\u3092\u89e3\u6790\u3059\u308b\u30c4\u30fc\u30eb\u3068\u3057\u3066\u6709\u7528\u3067\u3059\u3002 <!-- medsbase-related-alts-v1 --><\/p>\n<h2>Other Compounds for NAD-Axis and Metabolic Studies<\/h2>\n<ul>\n<li><a href=\"\/ja\/nad\/\"><strong>NAD\u207a<\/strong><\/a> \u2014 Oxidised dinucleotide coenzyme \u2014 direct NAD-pool supplementation studies<\/li>\n<li><a href=\"\/ja\/mots-c\/\"><strong>MOTS-c<\/strong><\/a> \u2014 Mitochondrial-derived peptide \u2014 metabolic and insulin sensitivity<\/li>\n<li><a href=\"\/ja\/ss-31-elamipretide\/\"><strong>SS-31 (Elamipretide)<\/strong><\/a> \u2014 \u30ab\u30eb\u30b8\u30aa\u30ea\u30d4\u30f3\u7d50\u5408\u6027\u30df\u30c8\u30b3\u30f3\u30c9\u30ea\u30a2\u6a19\u7684\u30da\u30d7\u30c1\u30c9<\/li>\n<li><a href=\"\/ja\/epitalon\/\"><strong>Epitalon<\/strong><\/a> \u2014 Pineal-axis tetrapeptide bioregulator \u2014 telomerase \/ longevity studies<\/li>\n<li><a href=\"\/ja\/l-carnitine\/\"><strong>L-\u30ab\u30eb\u30cb\u30c1\u30f3<\/strong><\/a> \u2014 \u30df\u30c8\u30b3\u30f3\u30c9\u30ea\u30a2\u9577\u9396\u8102\u80aa\u9178\u30b7\u30e3\u30c8\u30eb \u2014 \u4f75\u7528\u4f4e\u5206\u5b50<\/li>\n<li><a href=\"\/ja\/bac-water\/\"><strong>BAC Water\uff08\u9759\u83cc\u6c34\uff09<\/strong><\/a> \u2014 \u5168\u3066\u306e\u51cd\u7d50\u4e7e\u71e5\u30d0\u30a4\u30a2\u30eb\u306e\u518d\u6eb6\u89e3\u306b\u5fc5\u8981 \u2014 \u7121\u83cc\u30010.9%\u30d9\u30f3\u30b8\u30eb\u30a2\u30eb\u30b3\u30fc\u30eb\u4fdd\u5b58\u5e0c\u91c8\u6db2<\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>\u2705 \u9078\u629e\u7684\u5c0f\u5206\u5b50NNMT\uff08\u30cb\u30b3\u30c1\u30f3\u30a2\u30df\u30c9N-\u30e1\u30c1\u30eb\u30c8\u30e9\u30f3\u30b9\u30d5\u30a7\u30e9\u30fc\u30bc\uff09\u963b\u5bb3\u5264<br \/>\n\u2705 \u57fa\u8cea\u90e8\u4f4d\u6a19\u7684\u578b\uff1bIC\u2085\u2080 1.2 \u00b5M\uff1bGNMT\/PNMT\/COMT\/NAMPT\/NMNAT\u306b\u4f5c\u7528\u3057\u306a\u3044<br \/>\n\u2705 \u524d\u99c6\u4f53\u6d88\u8cbb\u306e\u7bc0\u7d04\u306b\u3088\u308a\u7d30\u80de\u5185NAD\u207a\u30fbSAM\u30d7\u30fc\u30eb\u3092\u5897\u52a0<br \/>\n\u2705 3T3-L1\u8102\u80aa\u7d30\u80de\u306e\u8102\u8cea\u751f\u6210\u3092\u6291\u5236\uff1bDIO\u30de\u30a6\u30b9\u30e2\u30c7\u30eb\u3067\u6d3b\u6027\u304c\u5831\u544a\u3055\u308c\u3066\u3044\u308b<br \/>\n\u2705 Small-molecule compound \u2014 not a peptide (MW 286.11, CAS 42464-96-0)<\/p>\n<p><strong>5-Amino-1MQ<\/strong> contains 5-amino-1-methylquinolinium iodide compound.<\/p>","protected":false},"featured_media":71430,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[6479,6483,6484,6481,6480,6482],"class_list":["post-71421","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-5-amino-1mq","product_tag-longevity-research","product_tag-metabolic-research","product_tag-nad-precursor-sparing","product_tag-nnmt-inhibitor","product_tag-research-compound","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/product\/71421","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/comments?post=71421"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/media\/71430"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/media?parent=71421"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/product_brand?post=71421"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/product_cat?post=71421"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/product_tag?post=71421"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}